Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

Not-for-Profit to Offer 20 Generic Drugs in 2019 to Alleviate Shortages

Jilian Mincer  |  January 25, 2019

(Reuters)—A new not-for-profit supplier of generic drugs formed by a consortium of hospitals systems said it expects this year to be able to provide about 20 products to alleviate shortages of medicines used during surgeries and to treat life-threatening conditions, such as septic shock. Since the start-up of Civica Rx spearheaded by Intermountain Healthcare was…

Filed under:Drug Updates Tagged with:Drug shortagegeneric drugsIntermountain Healthcare

Med Student Documentation Guidelines Need Careful Implementation

Will Boggs, MD  |  January 18, 2019

NEW YORK (Reuters Health)—New student-documentation guidelines from the Centers for Medicare and Medicaid Services (CMS) require careful implementation to avoid reductions in meaningful teaching physician involvement, according to a new report. The revised Medicare Claims Processing Manual allows the teaching physician to verify in the medical record any student documentation of services, rather than re-documenting…

Filed under:Career DevelopmentEducation & TrainingProfessional Topics Tagged with:Centers for Medicare & Medicaid Services (CMS)Medicare Claims Processing Manuastudent-documentation guidelines

2019 RheumPAC Resolutions

Zachary Wallace, MD, MSc  |  January 17, 2019

This year’s RheumPAC members are excited to build on their 2018 accomplishments. In 2018, we raised $144,000 from 323 individual investors. Thank you to everyone who invested and to those who supported advocacy for ACR/ARP, its members and our patients. We also introduced a new way for non-individuals (e.g., rheumatology practices, state and local rheumatology…

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:RheumPAC 2019 resolutionsRheumPAC Advocacy FundRheumPAC chair

The Rheumatology Research Foundation Honors 153 Award Recipients

From the College  |  January 17, 2019

CHICAGO—In October, the Rheumatology Research Foundation recognized 153 award and scholarship recipients at an awards luncheon, held in conjunction with the 2018 ACR/ARHP Annual Meeting. The annual event celebrates the accomplishments of rheumatology professionals who have received funding from the Foundation. In congratulating the award recipients, Foundation President Abby Abelson, MD, emphasized the impact the…

Filed under:AwardsFrom the CollegeResearch Rheum Tagged with:2018 ACR/ARHP Annual MeetingRheumatology Research Foundation

The Eliminating Kickbacks in Recovery Act of 2018—What Does It Mean?

Steven M. Harris, Esq.  |  January 17, 2019

It should not be a surprise to anyone that the U.S. is facing a national opioid crisis. It may be a surprise, however, that the federal government recently passed a law to address this crisis—a law that may have a profound impact on many healthcare facilities, some of which are not involved in the substance…

Filed under:Drug UpdatesLegal Updates Tagged with:opioid crisissubstance abuse

Dr. Christopher Morris: Rheumatologist, Bridge Player & Lifelong Magician

Carol Patton  |  January 17, 2019

Ever wonder how magicians know what card you pulled out of the deck, make objects vanish or unlink and link solid metal rings? Christopher Morris, MD, knows how these tricks are performed, but he won’t tell you. A rheumatologist who has been in private practice for 25 years at Arthritis Associates, Kingsport, Tenn., he has…

Filed under:AudioProfilesRheum After 5 Tagged with:Dr. Christopher Morris

Social & Psychological Elements Are Vital to Rheumatology Care

Thomas R. Collins  |  January 17, 2019

CHICAGO—To drive home the importance of how social determinants can make or break a person’s health, Jillian Rose, LCSW, MPH, the director of community, engagement, diversity and research at the Hospital for Special Surgery in New York City, told a story about a gardener planting flowers at the 2018 ACR/ARHP Annual Meeting. In the story,…

Filed under:ConditionsMeeting Reports Tagged with:2018 ACR/ARHP Annual MeetingAssociation of Rheumatology Professionals (ARP)biopsychosocial

DADA2: A New Disease for Rheumatologists to Understand

Jason Liebowitz, MD, FACR  |  January 17, 2019

BETHESDA, MD—Rheumatologists from the National Institutes of Health (NIH) and from Jerusalem, Israel, have identified deficiency of adenosine deaminase 2 (DADA2) as an important cause of familial polyarteritis nodosa, which tends to present in childhood and can manifest with hematologic, immunologic and inflammatory signs, says Chip Chambers, MD, founder and president of the DADA2 Foundation….

Filed under:ConditionsVasculitis Tagged with:deficiency of adenosine deaminase 2 (DADA2)Dr. Chip Chamberspolyarteritis nodosa

Get to Know the ARP’s Power Couple

Kelly Tyrrell  |  January 17, 2019

Bob and Jan Richardson’s separate paths to physical therapy and rheumatology involve wrestling and horses—although not at the same time. Their intertwining stories also involve a fair amount of serendipity. Mr. Bob Richardson For Bob Richardson, PT, MEd, the path started in the late 1950s, when he was wrapping up a fulfilling college wrestling career…

Filed under:Profiles Tagged with:Association of Rheumatology Professionals (ARP)Bob RichardsonDr. Jan RichardsonPhysical Therapy

A New Year’s Resolution: Use & Support the ACR’s Interprofessional Team

Hazel L. Breland, PhD, OTR/L, FAOTA, with Paula Marchetta, MD, MBA  |  January 17, 2019

Winston Churchill once said, “There is nothing wrong with change, if it is in the right direction.” So—with this, our first presidential column of 2019—we are bringing you news of a change or two. First, ARHP, our health professionals’ membership division, has changed its name to the Association of Rheumatology Professionals, or ARP. This new…

Filed under:President's Perspective Tagged with:Association of Rheumatology Professionals (ARP)interprofessional

  • « Previous Page
  • 1
  • …
  • 155
  • 156
  • 157
  • 158
  • 159
  • …
  • 332
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences